Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+77.9%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+77.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
5.6x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$22.31M+52.1%
2024$14.67M+15.4%
2023$12.71M+220.7%
2022$3.96M-
2021$0.00-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-100.0%
2016$1.16M-